Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
2024 · Nature Medicine · 69 citations
https://doi.org/10.1038/s41591-024-03086-4
J
Jasnoor Malhotra
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
56
Papers
725
Citations
9
h-index
8
i10-index
Jasnoor Malhotra is an academic researcher from Saint Louis University. The author has contributed to research in topics: Renal cell carcinoma treatment & Cancer Genomics and Diagnostics & Cancer Immunotherapy and Biomarkers. The author has an h-index of 9, co-authored 48 publications.
ORCID: 0000-0002-0056-2447Papers by this author
worksUltrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma
2023 · JCO Precision Oncology · 22 citations
https://doi.org/10.1200/po.22.00543
Feasibility and acceptability of a mindfulness app-based intervention among patients with metastatic renal cell carcinoma: a multinational study
2025 · The Oncologist · 3 citations
https://doi.org/10.1093/oncolo/oyae309
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat